AbbVie logo
AbbVie ABBV
$ 210.58 2.04%

Annual report 2025
added 02-20-2026

report update icon

AbbVie Cash Conversion Cycle 2011-2026 | ABBV

Annual Cash Conversion Cycle AbbVie

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
284 89.3 84.7 76.1 74.4 73.3 77.3 62.8 72.6 70.1 85.4 98.5 111 129 -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
284 62.8 99.1

Quarterly Cash Conversion Cycle AbbVie

2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
159 174 184 167 167 178 132 160 170 - 61.9 71.7 112 59 128 131 111 58.1 122 159 162 56.9 145 151 113 59.2 139 135 101 60 157 66.9 68.7 65.5 69.2 67.3 72.7 66.3 71.4 78.8 76.6 62.5 67.9 69.2 75.9 68.8 75.5 75 85.9 75.3 87 87.3 47 - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
184 47 103

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
257 $ 22.5 1.86 % $ 3.73 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
117 - -24.86 % $ 820 K usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
46.6 $ 327.16 2.39 % $ 42.9 B usaUSA
Amgen Amgen
AMGN
217 $ 349.22 2.71 % $ 188 B usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
205 $ 20.4 -0.87 % $ 954 M usaUSA
I-Mab I-Mab
IMAB
-1.97 K - - $ 866 M chinaChina
Aquestive Therapeutics Aquestive Therapeutics
AQST
-172 $ 4.18 1.33 % $ 447 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
158 $ 24.57 5.59 % $ 3.13 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-2.15 K - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
-58 - - $ 96.9 B britainBritain
Midatech Pharma plc Midatech Pharma plc
MTP
82.8 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
17 - -1.52 % $ 24.7 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
119 $ 1.48 8.46 % $ 394 M britainBritain
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
Advaxis Advaxis
ADXS
-143 K - -9.65 % $ 45.9 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
174 $ 2.71 5.51 % $ 17 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
85.5 - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
2.26 K - - $ 1.41 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Cerus Corporation Cerus Corporation
CERS
47 $ 1.9 2.99 % $ 362 M usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
149 $ 1.7 1.8 % $ 199 M usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
130 $ 0.36 0.28 % $ 4.12 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
-34.3 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
120 $ 25.57 2.3 % $ 3.13 B usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
-216 - - $ 1.2 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
-1.92 - 1.93 % $ 17.4 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
-1.6 K - -4.36 % $ 27 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
-101 - - $ 2.18 B usaUSA